期刊文献+

E1B缺陷性腺病毒对人恶性脑胶质瘤的溶瘤作用 被引量:1

The oncolytic effect of E1B mutant adenovirus on human malignant gliomas
原文传递
导出
摘要 目的研究E1B缺陷性腺病毒d11520对人恶性脑胶质瘤细胞株U251的体外溶瘤作用。方法按感染复数(MOI)为50、5、0.5、0.05、0.005、0pfu将E1B缺陷性腺病毒d11520感染常规培养的U251、Hep3B、T24细胞(Hep3B为阳性对照,T24为阴性对照1,结晶紫染色观察细胞病变(CPE)出现的时间;MOI为5pfu时病毒空斑试验检测d11520在3种细胞中的复制。将携带报告基因βgal的腺病毒载体Ad.βgal感染细胞,计算d11520对3种细胞的感染率。结果结晶紫染色结果显示Hep3B细胞对d11520最敏感、发生CPE效应最快,U251次之,而T24则不产生CPE效应;d11520在U251细胞中复制数和感染率均低于Hep3B细胞,但明显高于T24细胞,差异均有统计学意义俨〈0.05)。结论E1B缺陷性腺病毒d11520对人恶性脑胶质瘤细胞具有显著的溶瘤作用。 Objective To investigate the oncolytic effect of E1B mutant adenovirus (d11520) on human malignant gliomas. Methods Ad-βgal vector was used to investigate the infectibility of d11520. U251, Hep3B (positive control) and T24 (negative control) cell lines were infected with d11520 respectively at 50, 5, 0.5, 0.005 and 0 pfu of multiplicity of infection (MOI). The replication efficiency of d11520 in host cells was assessed by plaque assay. The cytopathic effect (CPE) was assessed by crystal violet staining in a panel of tumor cells. Results Crystal violet staining showed the Hep3B cell line was the most sensitive to dl1520 and had the fastest CPE, followed by the U251 cell line, while the T24 cell line had no CEP. The replication and infection rates ofdl1520 in the U251 cell line were lower than in the Hep3B cell line but significantly higher than in the T24 cell line (P〈0.05). Conclusion The E1B mutant adenovirus (d11520) has a significant oncolytic effect on human malignant gliomas.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2012年第3期235-237,共3页 Chinese Journal of Neuromedicine
关键词 神经胶质瘤 E1B缺陷性腺病毒 细胞病变效应 Gliomas E1B mutant adenovirus Cytopathic effect
  • 相关文献

参考文献7

  • 1刘华亭,杨天明.神经胶质瘤的治疗策略[J].现代生物医学进展,2011,11(5):958-960. 被引量:19
  • 2Stupp R, Mason WP, van den Bent MJ, et al. European organisation for research and treatment of cancer brain tumor and radiotherapy groups; national cancer institute of canada clinical trials group: radiotherapypius concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005, 352(10): 987-996.
  • 3Guse K, Hemminki A. Cancer gene therapy with oncolytic adenovirus[J]. J Buon, 2009, 14(suppl 1): s7-15.
  • 4Harada JH, Berk AJ. P53-independent and -dependent requirements for E1B-55K in adenovirus type 5 replication[J]. J Virus, 1999, 73 (7): 5333-5344.
  • 5Thomas R, Arnd H, Noel JW, et al. Replication of ONYX-015, a potential anticancer adenovirus, is independent of P53 status in tumor cells[J]. J Virol, 1998, 72(12): 9470-9478.
  • 6Beanehesne PD, Taillandie L. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study[J]. Cancer Chemo and Pharma, 2009, 64(9): 74-76.
  • 7Barnett BG, Crews C J, Douglas JT. Targeted adenoviral vectors[J]. Biochim Biophys Acta, 2002, 1575(1-3): 1-14.

二级参考文献9

  • 1傅志超,程惠华,赖红斌,林贵山,李东石,原锦.125例胶质瘤术后三维适形放疗临床研究的初步结果[J].中华放射医学与防护杂志,2007,27(2):164-167. 被引量:22
  • 2叶建平,詹怀义,王晓萍,李鸣.间质内高剂量率放射治疗脑重要功能区胶质瘤[J].临床肿瘤学杂志,2007,12(4):295-296. 被引量:6
  • 3Nobuhim MIKUNI,Susumu MIYAMOTO.Surgical Treatment for Glioma:Extent of Resection Applying Functional Neurosurgery [J]. Neurol Med Chir(Tokyo),2010,50:720-726.
  • 4Senti C., Franz K., Blasel S.,et al. Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme[J]. Technology in Cancer Research and Treatment ,2010, 9:4 (339-346).
  • 5Nimsky C, Ganslandt 0, von Keller B, et al. Preliminary experience in glioma surgery with intraoperative high-field MRI [J]. Acta Neurochir Supppt, 2003,88:21-29.
  • 6Di ez Valle R., Tejada Solis S., Idoate Gastearena M.A.et al. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. [Article in Press] Journal of Neuro-Oncology 2010.
  • 7Karim AB, Afra D, Cornu P, et al. Randomized trail on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: Euorpean Ogranization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BR04: an interim analysis Int[J]. J Radial Oncol Biol Phys,2002,52(2):L316-32.
  • 8胡成功,刘艳辉,毛庆,王鹏.“蝴蝶状”胼胝体胶质瘤的显微手术治疗[J].中华神经外科疾病研究杂志,2010,9(1):35-38. 被引量:7
  • 9杨开军,魏书航,漆松涛,王克万,武华坪.5-FU多聚缓释体植入技术治疗脑胶质瘤[J].中国微侵袭神经外科杂志,2004,9(6):245-247. 被引量:6

共引文献18

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部